Researchers call for greater caution, but skeptics say the evidence from rat studies is not convincing
By giving immunotherapies in tandem, researchers hope to broaden the benefits.
New U.S. law will require pediatric cancer clinic trials.
In May, the U.S. Preventive Services Task Force recommended against screening for thyroid cancer. After reviewing the available evidence, the task force concluded…
Most patients with chronic myeloid leukemia (CML) can live out their normal lives by taking tyrosine kinase inhibitors (TKIs). But mounting evidence also shows that roughly a third of those patients can eventually go off treatment altogether without their disease resurging.
Active surveillance is fast becoming a standard management practice for some men with prostate cancer.